136 related articles for article (PubMed ID: 37487908)
1. Treatment Individualization in Diffuse Large B-Cell Lymphoma: Is Frailty Enough for Old Adults? An Original Article.
García-Baztán A; Oteiza-Olaso J; Gonzales-Montejo NJ; Ramón-Espinoza MF; Tamayo-Rodríguez I; Martínez-Velilla N; Viguria-Alegria MC
Clin Lymphoma Myeloma Leuk; 2023 Oct; 23(10):e348-e359. PubMed ID: 37487908
[TBL] [Abstract][Full Text] [Related]
2. Geriatric risk model for older patients with diffuse large B-cell lymphoma (GERIAD): a prospective multicenter cohort study.
Yhim HY; Park Y; Kim JA; Shin HJ; Do YR; Moon JH; Kim MK; Lee WS; Kim DS; Lee MW; Choi YS; Jeong SH; Kim KH; Kim J; Lee CH; Song GY; Yang DH; Kwak JY
Korean J Intern Med; 2024 May; 39(3):501-512. PubMed ID: 38287501
[TBL] [Abstract][Full Text] [Related]
3. Hand grip strength, short physical performance battery, and gait speed: key tools for function in Non-Hodgkin Lymphoma.
García-Baztán A; Viguria-Alegria MC; Ramón-Espinoza MF; Tamayo-Rodríguez I; Gonzales-Montejo NJ; Martínez-Velilla N; Oteiza-Olaso J
Ann Hematol; 2023 Oct; 102(10):2823-2834. PubMed ID: 37566279
[TBL] [Abstract][Full Text] [Related]
4. A simplified frailty score predicts survival and can aid treatment-intensity decisions in older patients with DLBCL.
Isaksen KT; Mastroianni MA; Rinde M; Rusten LS; Barzenje DA; Ramslien LF; Slaaen M; Jerm MB; Smeland EB; Rostoft S; Liestøl K; Brodtkorb M; Holte H
Blood Adv; 2021 Nov; 5(22):4771-4782. PubMed ID: 34543384
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive Geriatric Assessment (CGA): A Simple Tool for Guiding the Treatment of Older Adults with Diffuse Large B-Cell Lymphoma in China.
Bai JF; Han HX; Feng R; Li JT; Wang T; Zhang CL; Liu H
Oncologist; 2020 Aug; 25(8):e1202-e1208. PubMed ID: 32436258
[TBL] [Abstract][Full Text] [Related]
6. Frailty assessment to individualize treatment in older patients with lymphoma.
Hormigo-Sanchez AI; Lopez-Garcia A; Mahillo-Fernandez I; Askari E; Morillo D; Perez-Saez MA; Riesco M; Urrutia C; Martinez-Peromingo FJ; Cordoba R; Gonzalez-Montalvo JI
Eur Geriatr Med; 2023 Dec; 14(6):1393-1402. PubMed ID: 37823983
[TBL] [Abstract][Full Text] [Related]
7. Utility of the frailty score for predicting prognosis and individualizing treatment intensity in elderly patients with diffuse large B cell lymphoma.
Yagi Y; Kanemasa Y; Sasaki Y; Goto S; Yamamura Y; Ishimine K; Hayashi Y; Mino M; Ohigashi A; Morita Y; Tamura T; Nakamura S; Okuya T; Shimoyama T
Ann Hematol; 2023 Jun; 102(6):1485-1500. PubMed ID: 37115298
[TBL] [Abstract][Full Text] [Related]
8. Diffuse Large B-Cell Lymphoma in the Elderly: Current Approaches.
Allen P
Curr Oncol Rep; 2020 Aug; 22(11):114. PubMed ID: 32827063
[TBL] [Abstract][Full Text] [Related]
9. Diffuse large B-cell lymphoma in very elderly patients: Towards best tailored treatment - A systematic review.
Tavares A; Moreira I
Crit Rev Oncol Hematol; 2021 Apr; 160():103294. PubMed ID: 33675907
[TBL] [Abstract][Full Text] [Related]
10. SWOG 1918: A phase II/III randomized study of R-miniCHOP with or without oral azacitidine (CC-486) in participants age 75 years or older with newly diagnosed aggressive non-Hodgkin lymphomas - Aiming to improve therapy, outcomes, and validate a prospective frailty tool.
Brem EA; Li H; Beaven AW; Caimi PF; Cerchietti L; Alizadeh AA; Olin R; Henry NL; Dillon H; Little RF; Laubach C; LeBlanc M; Friedberg JW; Smith SM
J Geriatr Oncol; 2022 Mar; 13(2):258-264. PubMed ID: 34686472
[TBL] [Abstract][Full Text] [Related]
11. A 10-Item Frailty Index Based on a Comprehensive Geriatric Assessment (FI-CGA-10) in Older Adults with Cancer: Development and Construct Validation.
Nishijima TF; Shimokawa M; Esaki T; Morita M; Toh Y; Muss HB
Oncologist; 2021 Oct; 26(10):e1751-e1760. PubMed ID: 34216413
[TBL] [Abstract][Full Text] [Related]
12. The Haemato-Oncology Frailty (HOF) score to assess frailty in lymphoma.
Ramdany H; Lofaro T; Deplano S
Eur J Haematol; 2024 Apr; 112(4):611-620. PubMed ID: 38112247
[TBL] [Abstract][Full Text] [Related]
13. Electronic FRAIL score as a predictor of treatment outcomes in older patients with diffuse large B-cell lymphoma.
Zhang J; Disperati P; Elinder-Camburn A; Merriman E; Leitch S; Chan H
J Geriatr Oncol; 2022 May; 13(4):505-510. PubMed ID: 34906444
[TBL] [Abstract][Full Text] [Related]
14. Physical frailty in patients with systemic sclerosis.
Hax V; Tessari J; Pena E; Santo RCDE; Dos Santos LP; Gasparin AA; Bredemeier M; Fighera TM; Spritzer PM; Xavier RM; Chakr RMDS
Semin Arthritis Rheum; 2022 Oct; 56():152077. PubMed ID: 35952534
[TBL] [Abstract][Full Text] [Related]
15. Measuring frailty in clinical practice: a comparison of physical frailty assessment methods in a geriatric out-patient clinic.
Pritchard JM; Kennedy CC; Karampatos S; Ioannidis G; Misiaszek B; Marr S; Patterson C; Woo T; Papaioannou A
BMC Geriatr; 2017 Nov; 17(1):264. PubMed ID: 29132301
[TBL] [Abstract][Full Text] [Related]
16. Patterns of improvement in functional ability and predictors of responders to dual-task exercise: A latent class analysis.
Ho V; Chan YH; Merchant RA
Front Public Health; 2022; 10():1069970. PubMed ID: 36699905
[TBL] [Abstract][Full Text] [Related]
17. The Role of Geriatric Assessment in the Management of Diffuse Large B-Cell Lymphoma.
Merli F; Pozzi S; Catellani H; Barbieri E; Luminari S
Cancers (Basel); 2023 Dec; 15(24):. PubMed ID: 38136390
[TBL] [Abstract][Full Text] [Related]
18. Frontline treatment of diffuse large B-cell lymphoma in elderly: a systematic review of clinical trials in post-rituximab era.
Beygi S; Sadashiv S; Reilly JB; Khan C; Lister J
Leuk Lymphoma; 2018 Dec; 59(12):2847-2861. PubMed ID: 29616868
[TBL] [Abstract][Full Text] [Related]
19. Ideal dose intensity of R-CHOP in diffuse large B-cell lymphoma.
Miura K; Takahashi H; Nakagawa M; Hamada T; Uchino Y; Iizuka K; Ohtake S; Iriyama N; Hatta Y; Nakamura H
Expert Rev Anticancer Ther; 2022 Jun; 22(6):583-595. PubMed ID: 35472312
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the frailty characteristics and clinical outcomes according to the new frailty-based outcome prediction model (Myeloma Risk Profile-MRP) in a UK real-world cohort of elderly newly diagnosed Myeloma patients.
Djebbari F; Rampotas A; Panitsas F; Lim WY; Lees C; Tsagkaraki I; Gomes AR; Prideaux S; Chen L; Prodger C; Khera A; Gray N; Ellis L; Sangha G; Eyre TA; Moore S; Kothari J; Ramasamy K
PLoS One; 2022; 17(1):e0262388. PubMed ID: 35015781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
